These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10128726)

  • 1. A successful community hospital program for monitoring adverse drug reactions.
    Saine DR
    Top Hosp Pharm Manage; 1992 Jul; 12(2):19-30. PubMed ID: 10128726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting adverse drug reactions is everyone's business: an adverse drug reaction reporting program that works.
    Burkhardt ME; Ripepe SD
    Top Hosp Pharm Manage; 1992 Jul; 12(2):31-9. PubMed ID: 10128727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the discharge process as one method to capture adverse drug reaction reports.
    Gee MA; Daniels BW
    Top Hosp Pharm Manage; 1992 Jul; 12(2):75-81. PubMed ID: 10128731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy-coordinated, multidisciplinary adverse drug reaction program.
    Swanson KM; Landry JP; Anderson RP
    Top Hosp Pharm Manage; 1992 Jul; 12(2):49-59. PubMed ID: 10136574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria-based adverse drug reaction reporting and the use of a relational database.
    Hatton RC
    Top Hosp Pharm Manage; 1992 Jul; 12(2):40-8. PubMed ID: 10128728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS; Nickman NA
    Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting a commercially available software program to improve ADR reporting.
    Ries AJ; Kraynak MA
    Formulary; 1995 Nov; 30(11):697-8, 703-4. PubMed ID: 10152873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective dosage adjustment program in a geriatric population.
    Guharoy SR
    Top Hosp Pharm Manage; 1994 Apr; 14(1):67-72. PubMed ID: 10171827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuous quality improvement team approach to adverse drug reaction reporting.
    Flowers P; Dzierba S; Baker O
    Top Hosp Pharm Manage; 1992 Jul; 12(2):60-7. PubMed ID: 10128729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of standardized screening procedures to identify adverse drug reactions.
    Koch KE
    Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary adverse drug reaction surveillance program.
    Prosser TR; Kamysz PL
    Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.